02.4Healthcare & Medical
Digital health
Digital health has to clear two bars at once (real clinical value and a viable business model) in a market where the buyer, the user, and the payer are often three different parties.
The terrain
What decides outcomes in this sector
Digital-health companies operate at the hardest intersection in the sector: they have to demonstrate genuine clinical outcomes and build a sustainable business, often while navigating a buyer (a health system or employer), a user (a patient), and a payer (an insurer) who are three separate parties with three sets of incentives. Product excellence alone doesn't resolve that; strategy does.
The graveyard is full of clinically promising companies that never solved the business model or the go-to-market. HIPAA's own breach rule gives a covered entity no more than 60 days to notify patients once a breach is discovered, which is a genuine operating constraint on any product handling patient data, not just a compliance footnote. We help digital-health companies find the reimbursement or enterprise path that makes the model work, sharpen the evidence and positioning, and decide which customer to build for first.
- Practice
- Healthcare & Medical
- Taxonomy
- 02.4
- Reach
- Worldwide
The hard calls
The decisions that carry the most weight
Pick the call in front of you. Each pairs with the services our practice maps to this sector: real pages, real scope, no packaged pitch.
01The three-party market problem
The buyer, user, and payer are often different, with different incentives. We help design the go-to-market around who actually pays and why, rather than assuming the user is the customer.
Where we start on calls like this
The services our practice maps to this sector.
- Strategy consultingChoose the customer, the wedge, and the business model in a three-party market.
- Sales consultingBuild the enterprise health-system or employer motion that actually closes.
- SEO consultingReach patients and buyers researching conditions and solutions across search and AI answers.
- Innovation consultingValidate the model and the reimbursement path before scaling spend.
02Clinical evidence as the price of entry
Without credible outcomes data, enterprise and payer doors stay shut. We help sequence evidence generation to the buying decisions it needs to clear.
Where we start on calls like this
The services our practice maps to this sector.
- Strategy consultingChoose the customer, the wedge, and the business model in a three-party market.
- Sales consultingBuild the enterprise health-system or employer motion that actually closes.
- SEO consultingReach patients and buyers researching conditions and solutions across search and AI answers.
- Innovation consultingValidate the model and the reimbursement path before scaling spend.
03Reimbursement or enterprise: pick the wedge
The viable path is usually reimbursement, an employer channel, or an enterprise health-system sale. We help choose the wedge and build the motion for it rather than chasing all three.
Where we start on calls like this
The services our practice maps to this sector.
- Strategy consultingChoose the customer, the wedge, and the business model in a three-party market.
- Sales consultingBuild the enterprise health-system or employer motion that actually closes.
- SEO consultingReach patients and buyers researching conditions and solutions across search and AI answers.
- Innovation consultingValidate the model and the reimbursement path before scaling spend.
04Retention and engagement as the model
Health outcomes and business outcomes both depend on sustained engagement. We help make engagement a strategic design problem, not a feature.
Where we start on calls like this
The services our practice maps to this sector.
- Strategy consultingChoose the customer, the wedge, and the business model in a three-party market.
- Sales consultingBuild the enterprise health-system or employer motion that actually closes.
- SEO consultingReach patients and buyers researching conditions and solutions across search and AI answers.
- Innovation consultingValidate the model and the reimbursement path before scaling spend.
Questions
What should you know about digital health before you reach out?
- We have great engagement but no revenue model can you help?
- That's one of the most common and most solvable problems here. The work is finding who genuinely pays (payer, employer, or health system), and building the evidence and motion to reach them, rather than assuming engagement converts on its own.
- Do you validate clinical efficacy?
- No. Clinical validation is your clinical team's and your trials' job. We help make sure the evidence you generate is sequenced and positioned to clear the buying decisions that make the business work.
Adjacent sectors
Related sectors
- 02.5Payers & health insurersHealth plans balancing medical cost, member experience, and regulatory pressure.
- 02.1Hospital & health systemsProvider organizations balancing care quality, margin, and system-wide change.
- 02.2Pharma & biotechDrug developers navigating long pipelines, heavy capital, and commercial strategy.
- 02.3Medical devicesDevice makers where regulation, reimbursement, and the sales channel decide adoption.
A strategy or operating decision that has to hold under real stakes?
Value-based-care positioning, AI governance, or a transformation that can't break clinical trust. Tell us what you're deciding, and we'll scope it honestly.
No obligation · a scoping conversation first